Anti-tumor effects of an Id antagonist with no acquired resistance

Paulina M. Wojnarowicz(Memorial Sloan Kettering Cancer Center), Robert Benezra(Memorial Sloan Kettering Cancer Center)
bioRxiv (Cold Spring Harbor Laboratory)
January 6, 2020
Cited by 3


Related Papers